| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 4.84e-06 | 265 | 95 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 5.59e-05 | 16 | 95 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.17e-04 | 62 | 95 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.86e-04 | 30 | 95 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.26e-04 | 31 | 95 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin binding | TRIM66 SP3 ERCC3 HDAC4 BRD4 MCM3AP FOXP1 MLLT10 FANCM PHC1 PHC2 | 7.66e-04 | 739 | 95 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 8.42e-04 | 320 | 95 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 8.44e-04 | 417 | 95 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 9.38e-04 | 326 | 95 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | helicase activity | 9.51e-04 | 158 | 95 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 9.75e-04 | 41 | 95 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | zinc ion binding | TET2 SEMG2 TRIM66 HDAC4 ZFHX4 SEC24A CIZ1 ZFHX3 UTRN CXXC1 PHC1 PHC2 | 1.05e-03 | 891 | 95 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.43e-03 | 562 | 95 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.81e-03 | 582 | 95 | 9 | GO:0140297 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | HDAC9 KMT2D ERCC3 HDAC4 BAZ2A UBAP2L MED9 BRD4 ZNF335 MCM3AP SYNE2 PAXIP1 AHR FANCM CXXC1 MED13 PHC1 PHC2 PASD1 | 7.14e-06 | 1377 | 92 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.00e-05 | 75 | 92 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | chromatin | TRIM66 SP3 PRDM10 HDAC4 ZFHX4 HOXD9 FOXP2 BRDT BAZ2A BAZ2B BRD4 AHR FOXP1 ZFHX3 SUPT20HL2 FANCM PHC1 PHC2 | 6.89e-05 | 1480 | 92 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | methyltransferase complex | 1.15e-04 | 108 | 92 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.91e-04 | 596 | 92 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | transferase complex | HDAC9 KMT2D ERCC3 BRD4 ZNF335 PAXIP1 PARD6G SUPT20HL2 DNA2 CXXC1 MED13 PHC1 PHC2 | 2.96e-04 | 963 | 92 | 13 | GO:1990234 |
| GeneOntologyCellularComponent | transcription repressor complex | 5.92e-04 | 87 | 92 | 4 | GO:0017053 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.23e-03 | 12 | 92 | 2 | GO:0044666 | |
| Domain | PHD | 1.05e-07 | 75 | 95 | 7 | PF00628 | |
| Domain | Znf_PHD-finger | 1.51e-07 | 79 | 95 | 7 | IPR019787 | |
| Domain | PHD | 3.45e-07 | 89 | 95 | 7 | SM00249 | |
| Domain | Znf_PHD | 4.02e-07 | 91 | 95 | 7 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.40e-07 | 95 | 95 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 5.80e-07 | 96 | 95 | 7 | PS01359 | |
| Domain | BROMODOMAIN_1 | 1.17e-06 | 37 | 95 | 5 | PS00633 | |
| Domain | Bromodomain | 1.35e-06 | 38 | 95 | 5 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.98e-06 | 41 | 95 | 5 | PS50014 | |
| Domain | BROMO | 2.24e-06 | 42 | 95 | 5 | SM00297 | |
| Domain | Bromodomain | 2.24e-06 | 42 | 95 | 5 | IPR001487 | |
| Domain | - | 2.24e-06 | 42 | 95 | 5 | 1.20.920.10 | |
| Domain | Bromodomain_CS | 8.62e-06 | 26 | 95 | 4 | IPR018359 | |
| Domain | Znf_FYVE_PHD | 1.00e-05 | 147 | 95 | 7 | IPR011011 | |
| Domain | BRD4_CDT | 2.56e-05 | 2 | 95 | 2 | IPR031354 | |
| Domain | Tyr_Pase_rcpt_a/e-type | 2.56e-05 | 2 | 95 | 2 | IPR016336 | |
| Domain | BRD4_CDT | 2.56e-05 | 2 | 95 | 2 | PF17105 | |
| Domain | Hist_deacetylase_Gln_rich_N | 7.65e-05 | 3 | 95 | 2 | IPR024643 | |
| Domain | HDAC4_Gln | 7.65e-05 | 3 | 95 | 2 | PF12203 | |
| Domain | WW | 9.48e-05 | 47 | 95 | 4 | PF00397 | |
| Domain | WW | 1.03e-04 | 48 | 95 | 4 | SM00456 | |
| Domain | WW_DOMAIN_2 | 1.31e-04 | 51 | 95 | 4 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.31e-04 | 51 | 95 | 4 | PS01159 | |
| Domain | WW_dom | 1.41e-04 | 52 | 95 | 4 | IPR001202 | |
| Domain | BET | 1.53e-04 | 4 | 95 | 2 | PF17035 | |
| Domain | FOXP-CC | 1.53e-04 | 4 | 95 | 2 | PF16159 | |
| Domain | FOXP-CC | 1.53e-04 | 4 | 95 | 2 | IPR032354 | |
| Domain | NET_dom | 1.53e-04 | 4 | 95 | 2 | IPR027353 | |
| Domain | Histone_deAcase_II_euk | 1.53e-04 | 4 | 95 | 2 | IPR017320 | |
| Domain | DDT | 1.53e-04 | 4 | 95 | 2 | PF02791 | |
| Domain | NET | 1.53e-04 | 4 | 95 | 2 | PS51525 | |
| Domain | Znf_C2H2_jaz | 1.83e-04 | 22 | 95 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 1.83e-04 | 22 | 95 | 3 | PF12171 | |
| Domain | DDT | 2.53e-04 | 5 | 95 | 2 | SM00571 | |
| Domain | Znf_FCS | 2.53e-04 | 5 | 95 | 2 | IPR012313 | |
| Domain | WSD | 2.53e-04 | 5 | 95 | 2 | PF15613 | |
| Domain | DDT_dom | 2.53e-04 | 5 | 95 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 2.53e-04 | 5 | 95 | 2 | IPR028941 | |
| Domain | Zinc_finger_PHD-type_CS | 3.35e-04 | 65 | 95 | 4 | IPR019786 | |
| Domain | CH | 3.35e-04 | 65 | 95 | 4 | SM00033 | |
| Domain | DDT | 3.79e-04 | 6 | 95 | 2 | PS50827 | |
| Domain | ZF_FCS | 3.79e-04 | 6 | 95 | 2 | PS51024 | |
| Domain | ZnF_U1 | 4.23e-04 | 29 | 95 | 3 | SM00451 | |
| Domain | Znf_U1 | 4.23e-04 | 29 | 95 | 3 | IPR003604 | |
| Domain | Spectrin_repeat | 4.23e-04 | 29 | 95 | 3 | IPR002017 | |
| Domain | CH | 4.45e-04 | 70 | 95 | 4 | PF00307 | |
| Domain | UBA | 4.69e-04 | 30 | 95 | 3 | SM00165 | |
| Domain | - | 4.70e-04 | 71 | 95 | 4 | 1.10.418.10 | |
| Domain | CH | 5.23e-04 | 73 | 95 | 4 | PS50021 | |
| Domain | Spectrin/alpha-actinin | 5.68e-04 | 32 | 95 | 3 | IPR018159 | |
| Domain | SPEC | 5.68e-04 | 32 | 95 | 3 | SM00150 | |
| Domain | CH-domain | 5.79e-04 | 75 | 95 | 4 | IPR001715 | |
| Domain | ResIII | 7.03e-04 | 8 | 95 | 2 | PF04851 | |
| Domain | - | 7.03e-04 | 8 | 95 | 2 | 3.30.890.10 | |
| Domain | Helicase/UvrB_N | 7.03e-04 | 8 | 95 | 2 | IPR006935 | |
| Domain | UBA | 8.06e-04 | 36 | 95 | 3 | PF00627 | |
| Domain | Hist_deacetyl | 1.37e-03 | 11 | 95 | 2 | PF00850 | |
| Domain | Methyl_CpG_DNA-bd | 1.37e-03 | 11 | 95 | 2 | IPR001739 | |
| Domain | MBD | 1.37e-03 | 11 | 95 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 1.37e-03 | 11 | 95 | 2 | IPR016177 | |
| Domain | His_deacetylse_dom | 1.37e-03 | 11 | 95 | 2 | IPR023801 | |
| Domain | - | 1.37e-03 | 11 | 95 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.37e-03 | 11 | 95 | 2 | IPR000286 | |
| Domain | MBD | 1.37e-03 | 11 | 95 | 2 | SM00391 | |
| Domain | MBD | 1.37e-03 | 11 | 95 | 2 | PS50982 | |
| Domain | UBA | 1.45e-03 | 44 | 95 | 3 | IPR015940 | |
| Domain | UBA | 1.76e-03 | 47 | 95 | 3 | PS50030 | |
| Domain | ZINC_FINGER_C2H2_1 | SP3 ZNF23 PRDM10 ZFHX4 FOXP2 ZNF382 ZNF335 CIZ1 FOXP1 ZFHX3 GPATCH8 | 1.95e-03 | 777 | 95 | 11 | PS00028 |
| Domain | - | 2.05e-03 | 449 | 95 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.35e-03 | 459 | 95 | 8 | IPR013083 | |
| Domain | Znf_C2H2-like | SP3 ZNF23 PRDM10 ZFHX4 FOXP2 ZNF382 ZNF335 CIZ1 FOXP1 ZFHX3 GPATCH8 | 2.36e-03 | 796 | 95 | 11 | IPR015880 |
| Domain | Znf_C2H2 | SP3 ZNF23 PRDM10 ZFHX4 FOXP2 ZNF382 ZNF335 CIZ1 FOXP1 ZFHX3 GPATCH8 | 2.57e-03 | 805 | 95 | 11 | IPR007087 |
| Domain | ZnF_C2H2 | SP3 ZNF23 PRDM10 ZFHX4 FOXP2 ZNF382 ZNF335 CIZ1 FOXP1 ZFHX3 GPATCH8 | 2.64e-03 | 808 | 95 | 11 | SM00355 |
| Domain | RmlC_Cupin | 2.93e-03 | 16 | 95 | 2 | IPR011051 | |
| Domain | UBA-like | 4.24e-03 | 64 | 95 | 3 | IPR009060 | |
| Domain | SAM_1 | 5.03e-03 | 68 | 95 | 3 | PF00536 | |
| Domain | TIR | 5.05e-03 | 21 | 95 | 2 | SM00255 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MICALL1 TET2 FSIP2 HDAC4 PHF3 PRRC2C SEC24A STXBP4 BRD4 SYNE2 AAK1 NAV2 MAGI3 HELZ PLEKHA5 FAM117B MTCL1 TTK UTRN DENND4C DCP1A | 1.98e-14 | 861 | 96 | 21 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MICALL1 KMT2D PPAN BAZ2A UBAP2L PHF3 BRD4 ZNF335 YLPM1 AAK1 HELZ GPATCH8 MED13 PPL PHC2 DCP1A | 3.93e-10 | 774 | 96 | 16 | 15302935 |
| Pubmed | TET2 KMT2D PPAN ZFHX4 FOXP2 UBAP2L PRRC2C SEC24A SYNE2 YLPM1 PAXIP1 HELZ FOXP1 ZFHX3 TNRC6C GPATCH8 MLLT10 CXXC1 DCP1A | 1.12e-08 | 1429 | 96 | 19 | 35140242 | |
| Pubmed | TET2 KMT2D ZFHX4 BRD4 PLEKHA5 FOXP1 ZFHX3 UTRN DENND4C PHC1 DCP1A | 2.34e-08 | 418 | 96 | 11 | 34709266 | |
| Pubmed | ERCC3 NCAPG UBAP2L ZC3H15 MED9 CIZ1 PAXIP1 KIF4A UTRN MED13 DENND4C PHC1 PHC2 | 2.69e-08 | 645 | 96 | 13 | 25281560 | |
| Pubmed | KMT2D NCAPG BAZ2A UBAP2L PHF3 PRRC2C BRD4 YLPM1 CIZ1 KIF4A PLEKHA5 DCP1A | 3.99e-08 | 549 | 96 | 12 | 38280479 | |
| Pubmed | 6.05e-08 | 268 | 96 | 9 | 33640491 | ||
| Pubmed | 2.84e-07 | 157 | 96 | 7 | 30186101 | ||
| Pubmed | SP3 FOXP2 BRDT BAZ2A ZC3H15 BRD4 CIZ1 AHR FOXP1 ZFHX3 MLLT10 CXXC1 PHC1 | 3.58e-07 | 808 | 96 | 13 | 20412781 | |
| Pubmed | 3.87e-07 | 101 | 96 | 6 | 10997877 | ||
| Pubmed | TRIM66 ZFHX4 FOXP2 BRDT PHLDA1 BAZ2A ZC3H15 BRD4 MCM3AP CIZ1 AHR HELZ FOXP1 ZFHX3 DNA2 | 4.13e-07 | 1116 | 96 | 15 | 31753913 | |
| Pubmed | 4.64e-07 | 23 | 96 | 4 | 9225980 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2D HOXD9 BAZ2A BAZ2B PHF3 MED9 BRD4 YLPM1 CIZ1 PAXIP1 KIF4A GPATCH8 FANCM CXXC1 RFWD3 PHC2 | 4.94e-07 | 1294 | 96 | 16 | 30804502 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.88e-07 | 351 | 96 | 9 | 38297188 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 9.10e-07 | 370 | 96 | 9 | 22922362 | |
| Pubmed | 1.36e-06 | 503 | 96 | 10 | 16964243 | ||
| Pubmed | 1.71e-06 | 130 | 96 | 6 | 12421765 | ||
| Pubmed | 2.14e-06 | 75 | 96 | 5 | 25593309 | ||
| Pubmed | SP3 PPAN ERCC3 BAZ2A PHF3 ZC3H15 AAK1 CIZ1 KIF4A ADGRG1 HELZ ZFHX3 GPATCH8 UTRN MED13 PHC2 | 3.28e-06 | 1497 | 96 | 16 | 31527615 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.82e-06 | 565 | 96 | 10 | 25468996 | |
| Pubmed | SP3 ZNF23 FOXP2 BAZ2A BRD4 AHR ZFHX3 MLLT10 MAML3 PHC1 DCP1A | 4.29e-06 | 709 | 96 | 11 | 22988430 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 5.10e-06 | 457 | 96 | 9 | 32344865 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | UBAP2L ZC3H15 SEC24A MCM3AP MYPN AAK1 PAXIP1 AHR PLEKHA5 TNRC6C DENND4C RFWD3 DCP1A | 5.66e-06 | 1038 | 96 | 13 | 26673895 |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30031127 | ||
| Pubmed | Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. | 7.54e-06 | 2 | 96 | 2 | 33637650 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15337775 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32192357 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28826859 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 7.54e-06 | 2 | 96 | 2 | 30104377 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30615487 | ||
| Pubmed | Conditional deletion of Ahr alters gene expression profiles in hematopoietic stem cells. | 7.54e-06 | 2 | 96 | 2 | 30388136 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 31356168 | ||
| Pubmed | Association of clonal hematopoiesis with chronic obstructive pulmonary disease. | 7.54e-06 | 2 | 96 | 2 | 34855941 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 7.54e-06 | 2 | 96 | 2 | 10873665 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24893771 | ||
| Pubmed | Protein tyrosine phosphatases ε and α perform nonredundant roles in osteoclasts. | 7.54e-06 | 2 | 96 | 2 | 24694598 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16870705 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 7.54e-06 | 2 | 96 | 2 | 15056695 | |
| Pubmed | KMT2D regulates activation, localization, and integrin expression by T-cells. | 7.54e-06 | 2 | 96 | 2 | 38765012 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25853299 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 27224915 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11358962 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28741757 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 7.54e-06 | 2 | 96 | 2 | 38761373 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 31311407 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26647308 | ||
| Pubmed | 9.35e-06 | 493 | 96 | 9 | 15368895 | ||
| Pubmed | 1.02e-05 | 103 | 96 | 5 | 32744500 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | BAZ2A UBAP2L ZC3H15 PRRC2C STXBP4 YLPM1 AAK1 CIZ1 KIF4A HELZ UTRN DCP1A | 1.04e-05 | 934 | 96 | 12 | 33916271 |
| Pubmed | 1.35e-05 | 653 | 96 | 10 | 22586326 | ||
| Pubmed | CACNA1A KIF21B HDAC4 FOXP2 UBAP2L PRRC2C SYNE2 YLPM1 AAK1 KIF4A PLEKHA5 MTCL1 | 1.40e-05 | 963 | 96 | 12 | 28671696 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.51e-05 | 398 | 96 | 8 | 35016035 | |
| Pubmed | 1.54e-05 | 399 | 96 | 8 | 35987950 | ||
| Pubmed | 1.77e-05 | 407 | 96 | 8 | 12693553 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.20e-05 | 203 | 96 | 6 | 22083510 | |
| Pubmed | 2.25e-05 | 20 | 96 | 3 | 35177643 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17215307 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 14516685 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28419090 | ||
| Pubmed | Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. | 2.26e-05 | 3 | 96 | 2 | 29662175 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 27333946 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 36314527 | ||
| Pubmed | Increased expression of hepcidin and toll-like receptors 8 and 10 in viral keratitis. | 2.26e-05 | 3 | 96 | 2 | 21499082 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 29379138 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 2.26e-05 | 3 | 96 | 2 | 19907493 | |
| Pubmed | Structural basis of molecular recognition of helical histone H3 tail by PHD finger domains. | 2.26e-05 | 3 | 96 | 2 | 28341809 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28507505 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23297420 | ||
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 2.26e-05 | 3 | 96 | 2 | 12687690 | |
| Pubmed | HDAC4 deacetylase associates with and represses the MEF2 transcription factor. | 2.26e-05 | 3 | 96 | 2 | 10487761 | |
| Pubmed | Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. | 2.26e-05 | 3 | 96 | 2 | 29769727 | |
| Pubmed | DNA hypermethylation is associated with invasive phenotype of malignant melanoma. | 2.26e-05 | 3 | 96 | 2 | 31602702 | |
| Pubmed | The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. | 2.26e-05 | 3 | 96 | 2 | 26551667 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 2.26e-05 | 3 | 96 | 2 | 25027557 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12598528 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19812040 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31754707 | ||
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 2.26e-05 | 3 | 96 | 2 | 28204507 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 9121482 | ||
| Pubmed | Characterization of BRD4 during mammalian postmeiotic sperm development. | 2.26e-05 | 3 | 96 | 2 | 25691659 | |
| Pubmed | 2.59e-05 | 209 | 96 | 6 | 36779422 | ||
| Pubmed | 2.66e-05 | 210 | 96 | 6 | 16565220 | ||
| Pubmed | MICALL1 UBAP2L ZC3H15 PRRC2C SEC24A AAK1 MAGI3 PLEKHA5 TTK DENND4C | 2.68e-05 | 708 | 96 | 10 | 39231216 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 3.02e-05 | 22 | 96 | 3 | 26886794 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.24e-05 | 724 | 96 | 10 | 36232890 | |
| Pubmed | 3.24e-05 | 65 | 96 | 4 | 22496869 | ||
| Pubmed | 3.91e-05 | 225 | 96 | 6 | 12168954 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 4.11e-05 | 69 | 96 | 4 | 28481362 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP3 ZNF23 KMT2D USF3 ZFHX4 HOXD9 FOXP2 ZC3H15 ZNF335 FOXP1 ZFHX3 | 4.23e-05 | 908 | 96 | 11 | 19274049 |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 14701752 | ||
| Pubmed | The aryl hydrocarbon receptor regulates lipid mediator production in alveolar macrophages. | 4.51e-05 | 4 | 96 | 2 | 37081886 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 23300874 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 31167772 | ||
| Pubmed | Expression of BET genes in testis of men with different spermatogenic impairments. | 4.51e-05 | 4 | 96 | 2 | 22035730 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 36652477 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 15511642 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 35045331 | ||
| Pubmed | HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. | 4.51e-05 | 4 | 96 | 2 | 30270123 | |
| Pubmed | Extrinsic Regulators of mRNA Translation in Developing Brain: Story of WNTs. | 4.51e-05 | 4 | 96 | 2 | 33525513 | |
| Pubmed | HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. | 4.51e-05 | 4 | 96 | 2 | 10523670 | |
| Interaction | PHIP interactions | 3.11e-08 | 197 | 95 | 10 | int:PHIP | |
| Interaction | YWHAH interactions | MICALL1 KIF21B TET2 HDAC4 PHF3 PRRC2C SEC24A STXBP4 BRD4 SYNE2 AAK1 NAV2 PARD6G MAGI3 PLEKHA5 FAM117B MTCL1 TTK UTRN DENND4C DCP1A | 3.28e-08 | 1102 | 95 | 21 | int:YWHAH |
| Interaction | TBR1 interactions | 6.16e-08 | 113 | 95 | 8 | int:TBR1 | |
| Interaction | FOXP3 interactions | HDAC9 SEMG2 ERCC3 NCAPG HDAC4 FOXP2 PHF3 AAK1 KIF4A HELZ FOXP1 MLLT10 PHC2 | 1.19e-07 | 432 | 95 | 13 | int:FOXP3 |
| Interaction | SMG7 interactions | TRIM66 KMT2D UBAP2L YLPM1 PAXIP1 HELZ TNRC6C GPATCH8 MLLT10 DNA2 DCP1A | 3.15e-07 | 319 | 95 | 11 | int:SMG7 |
| Interaction | FEV interactions | 4.97e-07 | 203 | 95 | 9 | int:FEV | |
| Interaction | YWHAG interactions | MICALL1 KIF21B TET2 HDAC4 PHF3 PRRC2C SEC24A STXBP4 SYNE2 AAK1 NAV2 MAGI3 HELZ PLEKHA5 FAM117B MTCL1 TTK UTRN DENND4C DCP1A | 1.17e-06 | 1248 | 95 | 20 | int:YWHAG |
| Interaction | EGR2 interactions | 1.48e-06 | 171 | 95 | 8 | int:EGR2 | |
| Interaction | GSC interactions | 3.47e-06 | 87 | 95 | 6 | int:GSC | |
| Interaction | ERG interactions | 1.05e-05 | 223 | 95 | 8 | int:ERG | |
| Interaction | TLE3 interactions | TET2 KMT2D BAZ2B SEC24A BRD4 MCM3AP HELZ ZFHX3 GPATCH8 MLLT10 | 1.12e-05 | 376 | 95 | 10 | int:TLE3 |
| Interaction | GCM1 interactions | 1.73e-05 | 68 | 95 | 5 | int:GCM1 | |
| Interaction | CRX interactions | 2.69e-05 | 254 | 95 | 8 | int:CRX | |
| Interaction | HNF1B interactions | 3.25e-05 | 190 | 95 | 7 | int:HNF1B | |
| Interaction | PHF21A interactions | 3.51e-05 | 343 | 95 | 9 | int:PHF21A | |
| Interaction | PLEC interactions | 3.54e-05 | 430 | 95 | 10 | int:PLEC | |
| Interaction | ERCC2 interactions | 4.04e-05 | 81 | 95 | 5 | int:ERCC2 | |
| Interaction | SOX7 interactions | 4.29e-05 | 82 | 95 | 5 | int:SOX7 | |
| Interaction | TNRC6C interactions | 4.87e-05 | 138 | 95 | 6 | int:TNRC6C | |
| Interaction | MED4 interactions | KIF21B ERCC3 NCAPG UBAP2L ZC3H15 MED9 BRD4 UTRN MED13 DENND4C | 5.18e-05 | 450 | 95 | 10 | int:MED4 |
| Interaction | CELF1 interactions | 6.55e-05 | 288 | 95 | 8 | int:CELF1 | |
| Interaction | FOXI1 interactions | 7.45e-05 | 92 | 95 | 5 | int:FOXI1 | |
| Interaction | SFN interactions | TET2 HDAC9 HDAC4 PHF3 PRRC2C STXBP4 AAK1 NAV2 PLEKHA5 FAM117B DENND4C DCP1A | 9.85e-05 | 692 | 95 | 12 | int:SFN |
| Interaction | CCT8L2 interactions | 9.97e-05 | 157 | 95 | 6 | int:CCT8L2 | |
| Interaction | EGLN3 interactions | TET2 ERCC3 NCAPG UBAP2L PHF3 SEC24A STXBP4 BRD4 AHR HELZ PLEKHA5 MTCL1 GPATCH8 TTK UTRN TARBP1 DCP1A | 1.06e-04 | 1296 | 95 | 17 | int:EGLN3 |
| Interaction | RCOR1 interactions | TRIM66 KMT2D NCAPG ZFHX4 BRD4 PLEKHA5 ZFHX3 UTRN DENND4C DCP1A | 1.12e-04 | 494 | 95 | 10 | int:RCOR1 |
| Interaction | ZBTB21 interactions | 1.14e-04 | 161 | 95 | 6 | int:ZBTB21 | |
| Interaction | SOX5 interactions | 1.18e-04 | 162 | 95 | 6 | int:SOX5 | |
| Interaction | SCMH1 interactions | 1.22e-04 | 54 | 95 | 4 | int:SCMH1 | |
| Interaction | YWHAZ interactions | MICALL1 TET2 HDAC9 FSIP2 PTPRA HDAC4 PHF3 SEC24A BRD4 SYNE2 AAK1 NAV2 PARD6G PLEKHA5 FAM117B DENND4C DCP1A | 1.32e-04 | 1319 | 95 | 17 | int:YWHAZ |
| Interaction | GARRE1 interactions | 1.40e-04 | 167 | 95 | 6 | int:GARRE1 | |
| Interaction | S100A2 interactions | 1.42e-04 | 412 | 95 | 9 | int:S100A2 | |
| Interaction | NUP35 interactions | 1.77e-04 | 424 | 95 | 9 | int:NUP35 | |
| Interaction | PAX8 interactions | 1.81e-04 | 111 | 95 | 5 | int:PAX8 | |
| Interaction | PTPN14 interactions | 1.92e-04 | 177 | 95 | 6 | int:PTPN14 | |
| Interaction | GIGYF1 interactions | 1.92e-04 | 177 | 95 | 6 | int:GIGYF1 | |
| Interaction | HDAC1 interactions | TET2 HDAC9 SP3 KMT2D NCAPG ZFHX4 BAZ2A BRD4 SYNE2 KIF4A PLEKHA5 ZFHX3 UTRN DENND4C DCP1A | 2.03e-04 | 1108 | 95 | 15 | int:HDAC1 |
| Interaction | AR interactions | TET2 KMT2D ERCC3 HDAC4 UBAP2L PHF3 BRD4 YLPM1 PAXIP1 AHR KIF4A FOXP1 ZFHX3 MED13 | 2.21e-04 | 992 | 95 | 14 | int:AR |
| Interaction | ALG13 interactions | 2.30e-04 | 183 | 95 | 6 | int:ALG13 | |
| Interaction | H2BC9 interactions | 2.57e-04 | 446 | 95 | 9 | int:H2BC9 | |
| Interaction | CTNNB1 interactions | KMT2D PTPRA HDAC4 MED9 BRD4 SYNE2 USP29 AHR MAGI3 PLEKHA5 FOXP1 FAM117B MLLT10 UTRN | 2.63e-04 | 1009 | 95 | 14 | int:CTNNB1 |
| Interaction | VSX1 interactions | 2.67e-04 | 66 | 95 | 4 | int:VSX1 | |
| Interaction | FAM120C interactions | 2.89e-04 | 191 | 95 | 6 | int:FAM120C | |
| Interaction | PAX7 interactions | 3.03e-04 | 124 | 95 | 5 | int:PAX7 | |
| Interaction | KLF5 interactions | 3.23e-04 | 195 | 95 | 6 | int:KLF5 | |
| Interaction | FOXL1 interactions | 3.32e-04 | 196 | 95 | 6 | int:FOXL1 | |
| Interaction | TNRC6A interactions | 3.61e-04 | 280 | 95 | 7 | int:TNRC6A | |
| Interaction | PAX9 interactions | 3.77e-04 | 130 | 95 | 5 | int:PAX9 | |
| Interaction | ZFHX4 interactions | 3.93e-04 | 73 | 95 | 4 | int:ZFHX4 | |
| Interaction | POU5F1 interactions | 4.29e-04 | 584 | 95 | 10 | int:POU5F1 | |
| Interaction | MAPKAPK2 interactions | 4.33e-04 | 134 | 95 | 5 | int:MAPKAPK2 | |
| Interaction | SETD1B interactions | 4.36e-04 | 75 | 95 | 4 | int:SETD1B | |
| Interaction | TLX3 interactions | 4.55e-04 | 291 | 95 | 7 | int:TLX3 | |
| Interaction | KDM1A interactions | TET2 KMT2D NCAPG ZFHX4 BRD4 PLEKHA5 FOXP1 ZFHX3 UTRN DENND4C PHC1 PHC2 DCP1A | 4.63e-04 | 941 | 95 | 13 | int:KDM1A |
| Interaction | TOP3B interactions | MICALL1 KMT2D HDAC4 UBAP2L SEC24A BRD4 ZNF335 MCM3AP PAXIP1 NAV2 HELZ TNRC6C MLLT10 DNA2 TNFRSF21 MED13 PHC2 | 4.71e-04 | 1470 | 95 | 17 | int:TOP3B |
| Interaction | MKRN2 interactions | 4.72e-04 | 385 | 95 | 8 | int:MKRN2 | |
| Interaction | HCFC1 interactions | 4.74e-04 | 293 | 95 | 7 | int:HCFC1 | |
| Interaction | NFIC interactions | 4.79e-04 | 210 | 95 | 6 | int:NFIC | |
| Interaction | FUBP3 interactions | 5.14e-04 | 297 | 95 | 7 | int:FUBP3 | |
| Cytoband | 9p22.1 | 3.87e-04 | 14 | 96 | 2 | 9p22.1 | |
| Cytoband | 14q21.2 | 8.02e-04 | 20 | 96 | 2 | 14q21.2 | |
| Cytoband | 19p13 | 1.47e-03 | 27 | 96 | 2 | 19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q32 | 1.63e-03 | 110 | 96 | 3 | chr2q32 | |
| Cytoband | 2q32.1 | 1.81e-03 | 30 | 96 | 2 | 2q32.1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.34e-08 | 25 | 72 | 5 | 775 | |
| GeneFamily | PHD finger proteins | 6.77e-08 | 90 | 72 | 7 | 88 | |
| GeneFamily | Histone deacetylases, class IIA | 9.34e-05 | 4 | 72 | 2 | 992 | |
| GeneFamily | CD molecules|Toll like receptors | 6.89e-04 | 10 | 72 | 2 | 948 | |
| GeneFamily | UPF1 like RNA helicases | 8.40e-04 | 11 | 72 | 2 | 1169 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 8.40e-04 | 11 | 72 | 2 | 1025 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.59e-03 | 15 | 72 | 2 | 529 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.13e-03 | 21 | 72 | 2 | 813 | |
| GeneFamily | Sterile alpha motif domain containing | 5.22e-03 | 88 | 72 | 3 | 760 | |
| GeneFamily | Cyclins|Mediator complex | 7.62e-03 | 33 | 72 | 2 | 1061 | |
| GeneFamily | Zinc fingers CCCH-type | 8.55e-03 | 35 | 72 | 2 | 73 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 PTPRA HDAC4 BAZ2B PHF3 PRRC2C SEC24A SYNE2 HELZ TOGARAM1 ZFHX3 KAZN MTCL1 GPATCH8 TTK MED13 | 8.40e-08 | 856 | 96 | 16 | M4500 |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 7.46e-07 | 200 | 96 | 8 | M8648 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | DAGLB TET2 CLCA1 HDAC4 BAZ2B UBAP2L PRRC2C BRD4 ZFHX3 CXXC1 RFWD3 | 1.15e-06 | 467 | 96 | 11 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | DAGLB TET2 CLCA1 HDAC4 BAZ2B UBAP2L PRRC2C BRD4 ZFHX3 CXXC1 RFWD3 | 1.63e-06 | 484 | 96 | 11 | MM999 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 1.69e-06 | 155 | 96 | 7 | M8944 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | PRDM10 BAZ2A BAZ2B PHF3 STK17B SEC24A BRD4 AHR NAV2 GPATCH8 DENND4C PPL DCP1A PLIN2 | 1.76e-06 | 822 | 96 | 14 | M6782 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.57e-06 | 180 | 96 | 7 | M8239 | |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 9.10e-06 | 200 | 96 | 7 | M5995 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TET2 HDAC9 PTPRE FOXP2 BAZ2B PRRC2C YLPM1 AHR NAV2 PARD6G HELZ FOXP1 ZFHX3 KAZN TNFRSF21 | 1.11e-05 | 1102 | 96 | 15 | M2369 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.13e-05 | 38 | 96 | 4 | M39244 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TET2 HDAC9 PTPRE FOXP2 BAZ2B PRRC2C YLPM1 AHR NAV2 PARD6G HELZ FOXP1 ZFHX3 KAZN TNFRSF21 | 1.40e-05 | 1124 | 96 | 15 | MM1070 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.49e-05 | 300 | 96 | 8 | M8702 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | DAGLB ANKRD36B KIF21B TRIM66 PTPRE MCM3AP AAK1 AHR ADGRG1 ZFHX3 ANKRD36 UTRN CXXC1 | 2.60e-05 | 905 | 96 | 13 | M40865 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 3.41e-05 | 166 | 96 | 6 | M6826 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 4.73e-05 | 176 | 96 | 6 | M8952 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 4.99e-05 | 55 | 96 | 4 | MM397 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 6.59e-05 | 478 | 96 | 9 | M45785 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 8.83e-05 | 197 | 96 | 6 | M8464 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP | 9.60e-05 | 200 | 96 | 6 | M3312 | |
| Coexpression | GSE17721_CTRL_VS_CPG_2H_BMDC_DN | 9.60e-05 | 200 | 96 | 6 | M3760 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP | 9.60e-05 | 200 | 96 | 6 | M9942 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 9.60e-05 | 200 | 96 | 6 | M9273 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B SP3 KMT2D PTPRA PTPRE PHLDA1 PHF3 STK17B AAK1 AHR HELZ TNRC6C GPATCH8 UTRN MED13 DCP1A | 9.86e-05 | 1492 | 96 | 16 | M40023 |
| Coexpression | GAZIN_EPIGENETIC_SILENCING_BY_KRAS | 1.03e-04 | 25 | 96 | 3 | M1770 | |
| Coexpression | GAZIN_EPIGENETIC_SILENCING_BY_KRAS | 1.31e-04 | 27 | 96 | 3 | MM744 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | KIF21B HDAC9 PTPRE BAZ2A BAZ2B SEC24A AAK1 PLEKHA5 UTRN MAML3 PLIN2 | 1.31e-04 | 778 | 96 | 11 | M17915 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.82e-04 | 429 | 96 | 8 | M29 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | HDAC9 SP3 PTPRE SEC24A YLPM1 TOGARAM1 FOXP1 ZFHX3 NCKAP5 DNA2 MED13 | 1.25e-05 | 492 | 95 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | MICALL1 HDAC9 SP3 NCAPG CLCA1 ZFHX4 FOXP2 PHF3 PLEKHA5 FOXP1 MTCL1 UTRN MED13 DCP1A | 1.46e-05 | 811 | 95 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | HDAC9 SP3 CLCA1 PTPRE ZFHX4 FOXP2 SEC24A YLPM1 TOGARAM1 FOXP1 ZFHX3 NCKAP5 DNA2 MED13 | 2.04e-05 | 836 | 95 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 4.30e-05 | 209 | 95 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.56e-05 | 478 | 95 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.74e-05 | 385 | 95 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | HDAC9 SP3 CLCA1 ZFHX4 FOXP2 PHLDA1 PHF3 PARD6G PLEKHA5 FOXP1 MTCL1 MED13 DCP1A | 6.08e-05 | 806 | 95 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | MICALL1 KIF21B SP3 ERCC3 FOXP2 UBAP2L MCM3AP PARD6G TOGARAM1 ZFHX3 UTRN | 7.29e-05 | 597 | 95 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.97e-05 | 312 | 95 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.04e-04 | 416 | 95 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | HDAC9 SP3 CLCA1 PTPRE ZFHX4 FOXP2 SEC24A SYNE2 YLPM1 FOXP1 ZFHX3 NCKAP5 RFWD3 | 1.04e-04 | 850 | 95 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CACNA1A TET2 SP3 ZNF23 FOXP2 UBAP2L STXBP4 BRD4 SYNE2 YLPM1 ADGRG1 ZFHX3 FANCM DNA2 TTK PHC1 | 1.29e-04 | 1252 | 95 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.34e-04 | 532 | 95 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HDAC9 TRIM66 SP3 ZNF23 NCAPG CLCA1 BRDT UBAP2L STK17B SYNE2 NAV2 UTRN | 1.77e-04 | 776 | 95 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP3 ZNF23 NCAPG CLCA1 PTPRE HOXD9 BRDT UBAP2L PRRC2C SYNE2 NAV2 UTRN | 2.50e-04 | 806 | 95 | 12 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CLCA1 HDAC4 ZFHX4 FOXP2 PHF3 PARD6G PLEKHA5 FOXP1 MTCL1 TNRC6C GPATCH8 MED13 | 2.50e-04 | 806 | 95 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | ZNF23 CLCA1 ZFHX4 FOXP2 PHF3 BRD4 PARD6G PLEKHA5 FOXP1 ZFHX3 MED13 DCP1A | 2.86e-04 | 818 | 95 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 3.17e-04 | 382 | 95 | 8 | GSM476684_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.91e-04 | 138 | 95 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.10e-04 | 397 | 95 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.83e-04 | 407 | 95 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 4.91e-04 | 408 | 95 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.03e-10 | 199 | 96 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 6.84e-09 | 185 | 96 | 8 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.21e-08 | 199 | 96 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.27e-08 | 162 | 96 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.00e-07 | 192 | 96 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.07e-07 | 193 | 96 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-07 | 197 | 96 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.63e-07 | 200 | 96 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-06 | 162 | 96 | 6 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-06 | 162 | 96 | 6 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 165 | 96 | 6 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 167 | 96 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.93e-06 | 171 | 96 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.68e-06 | 181 | 96 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-06 | 187 | 96 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.44e-06 | 189 | 96 | 6 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-06 | 190 | 96 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.54e-06 | 190 | 96 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-06 | 191 | 96 | 6 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-06 | 191 | 96 | 6 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.65e-06 | 191 | 96 | 6 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.76e-06 | 192 | 96 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.88e-06 | 193 | 96 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.88e-06 | 193 | 96 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.11e-06 | 195 | 96 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-06 | 195 | 96 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.11e-06 | 195 | 96 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.24e-06 | 196 | 96 | 6 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.24e-06 | 196 | 96 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.36e-06 | 197 | 96 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.36e-06 | 197 | 96 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 4.36e-06 | 197 | 96 | 6 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 4.49e-06 | 198 | 96 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.62e-06 | 199 | 96 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | fdd8c4c04837341e17a4772a2adcdf2f187c56b1 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 4.62e-06 | 199 | 96 | 6 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-06 | 199 | 96 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-06 | 200 | 96 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 4.76e-06 | 200 | 96 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 4.76e-06 | 200 | 96 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.11e-05 | 135 | 96 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.32e-05 | 140 | 96 | 5 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.67e-05 | 147 | 96 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.90e-05 | 151 | 96 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.23e-05 | 156 | 96 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 2.83e-05 | 164 | 96 | 5 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 164 | 96 | 5 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 167 | 96 | 5 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.27e-05 | 169 | 96 | 5 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 169 | 96 | 5 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 171 | 96 | 5 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 171 | 96 | 5 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 171 | 96 | 5 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 171 | 96 | 5 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 171 | 96 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 174 | 96 | 5 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 174 | 96 | 5 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.76e-05 | 174 | 96 | 5 | c8cec89369cf3896c5626e447051e76a142cb6df | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.97e-05 | 176 | 96 | 5 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-05 | 177 | 96 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.19e-05 | 178 | 96 | 5 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 179 | 96 | 5 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 179 | 96 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.30e-05 | 179 | 96 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-05 | 180 | 96 | 5 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 4.90e-05 | 184 | 96 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.03e-05 | 185 | 96 | 5 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN1_thymic_pro-T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.03e-05 | 185 | 96 | 5 | 5db31631a4b4c4bfeb28f02d8dab00a48d77bcba | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.16e-05 | 186 | 96 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.16e-05 | 186 | 96 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.16e-05 | 186 | 96 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.43e-05 | 188 | 96 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 188 | 96 | 5 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 188 | 96 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.43e-05 | 188 | 96 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 188 | 96 | 5 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 188 | 96 | 5 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 5.43e-05 | 188 | 96 | 5 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.56e-05 | 189 | 96 | 5 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 189 | 96 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.56e-05 | 189 | 96 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 190 | 96 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-05 | 190 | 96 | 5 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.70e-05 | 190 | 96 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-05 | 191 | 96 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A | 1.68e-06 | 196 | 95 | 8 | 5510_UP | |
| Drug | AC1L2FXT | 8.27e-06 | 10 | 95 | 3 | CID000071316 | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.45e-05 | 189 | 95 | 7 | 2695_UP | |
| Drug | AC1L2XIZ | 1.51e-05 | 12 | 95 | 3 | CID000104803 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A | 1.66e-05 | 193 | 95 | 7 | 455_UP | |
| Drug | Succimer | CACNA1A KIF21B TET2 HDAC9 ZFHX4 PHLDA1 BAZ2B UBAP2L PHF3 ZC3H15 STXBP4 NAV2 HELZ FOXP1 MLLT10 UTRN MED13 | 1.70e-05 | 1264 | 95 | 17 | ctd:D004113 |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 2848_UP | |
| Drug | Magnetite Nanoparticles | CACNA1A KIF21B TET2 HDAC9 ZFHX4 PHLDA1 BAZ2B UBAP2L PHF3 ZC3H15 STXBP4 NAV2 HELZ FOXP1 MLLT10 UTRN MED13 | 2.68e-05 | 1310 | 95 | 17 | ctd:D058185 |
| Disease | breast cancer, ovarian carcinoma | 6.14e-06 | 37 | 95 | 4 | EFO_0001075, MONDO_0007254 | |
| Disease | urinary albumin to creatinine ratio | 2.55e-05 | 179 | 95 | 6 | EFO_0007778 | |
| Disease | taste liking measurement | 3.73e-05 | 388 | 95 | 8 | EFO_0010155 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 6.13e-05 | 4 | 95 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 7.22e-05 | 550 | 95 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | cortical surface area measurement | CACNA1A TET2 HDAC9 FOXP2 BAZ2B STK17B PRRC2C NAV2 FOXP1 ZFHX3 NCKAP5 FAM117B MTCL1 PHC2 | 1.01e-04 | 1345 | 95 | 14 | EFO_0010736 |
| Disease | prostate carcinoma | TET2 SP3 SYNE2 ADGRG1 FOXP1 ZFHX3 ANKRD36 GPATCH8 TTK MAML3 PPL | 1.39e-04 | 891 | 95 | 11 | EFO_0001663 |
| Disease | coffee consumption | 1.50e-04 | 32 | 95 | 3 | EFO_0004330 | |
| Disease | attention deficit hyperactivity disorder | 1.51e-04 | 354 | 95 | 7 | EFO_0003888 | |
| Disease | Paroxysmal atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.53e-04 | 156 | 95 | 5 | C2585653 | |
| Disease | Prostatic Neoplasms | 1.69e-04 | 616 | 95 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.69e-04 | 616 | 95 | 9 | C0376358 | |
| Disease | Atrial Fibrillation | 1.72e-04 | 160 | 95 | 5 | C0004238 | |
| Disease | body weight | TET2 TRIM66 USF3 FOXP2 PHF3 STXBP4 AAK1 ZFHX3 KAZN MLLT10 DNA2 MAML3 PHC2 | 2.00e-04 | 1261 | 95 | 13 | EFO_0004338 |
| Disease | hypersomnia | 2.13e-04 | 7 | 95 | 2 | EFO_0005246 | |
| Disease | trauma exposure measurement | 2.41e-04 | 172 | 95 | 5 | EFO_0010703 | |
| Disease | multisite chronic pain | 2.57e-04 | 95 | 95 | 4 | EFO_0010100 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.60e-04 | 801 | 95 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | reaction time measurement | 2.76e-04 | 658 | 95 | 9 | EFO_0008393 | |
| Disease | gastroesophageal reflux disease | 3.24e-04 | 101 | 95 | 4 | EFO_0003948 | |
| Disease | Congenital Heart Defects | 3.89e-04 | 44 | 95 | 3 | C0018798 | |
| Disease | abdominal aortic calcification measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0010272 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 5.54e-04 | 11 | 95 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | neuroimaging measurement | KIF21B HDAC9 FOXP2 STK17B PRRC2C NAV2 FOXP1 NCKAP5 MLLT10 DENND4C PLIN2 | 6.50e-04 | 1069 | 95 | 11 | EFO_0004346 |
| Disease | brain volume measurement | 6.81e-04 | 595 | 95 | 8 | EFO_0006930 | |
| Disease | Autosomal recessive primary microcephaly | 1.05e-03 | 15 | 95 | 2 | cv:C3711387 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.08e-03 | 139 | 95 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | anthranilic acid measurement | 1.20e-03 | 16 | 95 | 2 | EFO_0010460 | |
| Disease | S-6-hydroxywarfarin measurement | 1.24e-03 | 368 | 95 | 6 | EFO_0803326 | |
| Disease | sphingomyelin 14:0 measurement | 1.35e-03 | 17 | 95 | 2 | EFO_0010390 | |
| Disease | synophrys measurement | 1.39e-03 | 68 | 95 | 3 | EFO_0007906 | |
| Disease | Contact Dermatitis | 1.58e-03 | 71 | 95 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 1.58e-03 | 71 | 95 | 3 | C0162351 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | pulse pressure measurement | TET2 HDAC9 TRIM66 ZFHX4 MYPN FOXP1 ZFHX3 GPATCH8 ANKRD36C DENND4C PHC2 PLIN2 | 1.70e-03 | 1392 | 95 | 12 | EFO_0005763 |
| Disease | vital capacity | TET2 HDAC9 TRIM66 BRD4 MYPN AHR FOXP1 ZFHX3 MTCL1 MLLT10 UTRN | 2.08e-03 | 1236 | 95 | 11 | EFO_0004312 |
| Disease | age of onset of asthma | 2.14e-03 | 79 | 95 | 3 | OBA_2001001 | |
| Disease | risky sexual behaviour measurement | 2.21e-03 | 169 | 95 | 4 | EFO_0007877 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.38e-03 | 566 | 95 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | testosterone measurement | DAGLB TET2 ZFHX4 MED9 SYNE2 MYPN FOXP1 ZFHX3 KAZN UTRN PLIN2 | 2.65e-03 | 1275 | 95 | 11 | EFO_0004908 |
| Disease | cup-to-disc ratio measurement | 2.70e-03 | 430 | 95 | 6 | EFO_0006939 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 2.70e-03 | 24 | 95 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | childhood trauma measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0007979 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 2.91e-03 | 88 | 95 | 3 | EFO_0000341, EFO_0006527 | |
| Disease | Fanconi Anemia | 2.93e-03 | 25 | 95 | 2 | C0015625 | |
| Disease | cortical thickness | MICALL1 HDAC9 FOXP2 STK17B YLPM1 NAV2 FOXP1 NCKAP5 MTCL1 MLLT10 | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 |
| Disease | HVA measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0005131 | |
| Disease | nevus count, cutaneous melanoma | 3.20e-03 | 91 | 95 | 3 | EFO_0000389, EFO_0004632 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQQQHHQKQVVVEPQ | 621 | P35869 | |
| HQKQVVVEPQQQLCQ | 626 | P35869 | |
| PPLNHTVVQVNKNAN | 1176 | O00555 | |
| QAQATPQHQQQLFLK | 456 | Q2M2I8 | |
| VHEQLAALSQPQQNK | 521 | O60885 | |
| KAVHQQLQVLSQVPF | 431 | Q58F21 | |
| AQPQPQLQLQLQSHK | 1231 | Q9UIF9 | |
| QTHSFQSQQKQPQVL | 336 | Q9UIF8 | |
| YENNQPQVKNQIHSR | 1311 | A6QL64 | |
| NNQPQVKNQIHSRDD | 751 | Q8N2N9 | |
| QKLRLTPQHDQIQTQ | 396 | Q9NPI6 | |
| QKLTSHQSQNLQQPR | 401 | Q6PCD5 | |
| GQPHKQVVENQQLFS | 1126 | Q9Y4B5 | |
| NNQPQVKNQIHSRDD | 1176 | Q5JPF3 | |
| PTKNLEQQVNHSQQG | 366 | Q6ZW49 | |
| IAAVQKQQQQTGNHP | 611 | P23469 | |
| VQKNLHNPIVQSLED | 356 | Q674X7 | |
| PQNAQALQHLVIQQQ | 471 | P56524 | |
| ENQPEIKHQSLLQKN | 1176 | Q5TCQ9 | |
| QQILAEQQLQQSHLP | 771 | Q96JK9 | |
| GQNNANIIHTPTKQQ | 1426 | Q5HYC2 | |
| HKHNQNENLVPNNRV | 1086 | Q8IYD8 | |
| QTQPVLQSQVENLLH | 1701 | O60318 | |
| ILAKQLHNIPENNQI | 161 | Q5CZC0 | |
| NVKPAALQQQLENIH | 86 | Q9Y6G5 | |
| AAQQHIQQQLLAKQV | 1326 | Q9UKJ3 | |
| VTHTQKVVLQQDPQQ | 1441 | O60437 | |
| QQQQQQHPGKQAKEQ | 186 | O15409 | |
| QHPGKQAKEQQQQQQ | 191 | O15409 | |
| LDQQELIQQIPNAHK | 1531 | O75037 | |
| LQLLQQQHAGKQPKE | 156 | Q9H334 | |
| KEEEKQHSQPQQQQL | 256 | P28356 | |
| QPKQQHQQQLAEDAK | 236 | Q8N3F8 | |
| QSASGLQQPQHIQLQ | 931 | Q9NQV6 | |
| FPIPQQHTLLNQQQN | 1371 | P42694 | |
| GIHLSPEQQQQQLQS | 106 | Q9NWA0 | |
| HNLIVTVKPANQRNN | 241 | Q9BYG4 | |
| EQQKQQLQEQPLKHN | 561 | Q8IV76 | |
| QLQEQPLKHNVIVGN | 566 | Q8IV76 | |
| PSQHHQQQQQQIKRS | 151 | Q9P0U4 | |
| VIQQVVDNPQHKTQL | 231 | Q96DR5 | |
| LLHQQQDNIRNNQEP | 241 | Q8NCG7 | |
| FQLKQQQQQQHGSPT | 41 | Q6P1L5 | |
| QGPQLRQQQHKQNKQ | 141 | Q9NNZ3 | |
| RQSIQHNNVLKPINL | 1816 | Q5VZ89 | |
| LTFQHQLQPKNVTLQ | 331 | Q9Y653 | |
| PQTAELNHLKQQVQQ | 346 | O95239 | |
| QILQNFKHNPKINTI | 591 | P19447 | |
| QLVIQQQHQQFLEKQ | 461 | Q9UKV0 | |
| QIQKVHPAIQQFTEQ | 701 | P51530 | |
| VQKQQQQSGNHPITV | 716 | P18433 | |
| KQHKLNQNDQLLSVP | 2891 | P46939 | |
| QHQRQLAQALLVKQP | 1201 | Q9HCJ0 | |
| EDVNKTLPNLQVVNH | 286 | O75509 | |
| NNNQIQTVPKETIHL | 451 | Q9BXR5 | |
| SLHVLNQIKSQLQQP | 3161 | Q8WXH0 | |
| QNPQQQKLVKPTHNI | 766 | O14513 | |
| HQHNPVQVQKLQKEL | 721 | O95486 | |
| KQQQQQPQKQHLSSP | 191 | Q8IVL1 | |
| QTQAQTHKPVQNPLQ | 1931 | Q9Y520 | |
| QNNIVHLDLKPQNIL | 151 | O94768 | |
| QIHGKSQNQVRIPSQ | 381 | Q02383 | |
| LGQQQQILPKHKTNE | 446 | Q9UHV7 | |
| PTKEQHQALRQQVQA | 231 | Q6ZWJ1 | |
| EKEQLQQQLQQHGPV | 386 | Q499Z3 | |
| QSHQLVSLQQLQQPT | 666 | P0C7V6 | |
| QLLNSQQLTPEQHQA | 976 | P55197 | |
| LAQQPHQNQAKLVVA | 16 | Q9BPX3 | |
| TEQNHNKEAPNKQNQ | 251 | A8K7I4 | |
| QTQTSPEHLVLQQKQ | 346 | Q9ULV3 | |
| PEHLVLQQKQVQPQL | 351 | Q9ULV3 | |
| AHSQPPRQVQLQLQK | 411 | Q9ULV3 | |
| LQNLTKINLNHNPNV | 86 | Q9NR97 | |
| KINLNHNPNVQHQNG | 91 | Q9NR97 | |
| SKHLQPQFVIQQQPQ | 341 | Q8IXK0 | |
| PAQIQMQLQHELQQQ | 1646 | Q86UP3 | |
| NQTQHKQRPQATAEQ | 21 | Q14157 | |
| QNLFPSINVHKVNLN | 161 | Q9NQ55 | |
| RQKQQHLVQQQPPSQ | 296 | Q8WV24 | |
| QNNSPQLNNVLEHLV | 276 | C9JQI7 | |
| AQPVVQHLQLQESQQ | 391 | Q02447 | |
| KAQVPLDSHSQQLQQ | 271 | Q9HBJ7 | |
| LHKQRNKPQQNLQED | 1406 | Q92576 | |
| YTQIQPHSLIQQQQQ | 371 | P78364 | |
| NVSHNLQKQTANVVP | 171 | Q68DE3 | |
| HLNNPQKTGQRTQEN | 2526 | O00507 | |
| QQHQQQPKSQAEPLS | 846 | P49750 | |
| FQQQQHQILATPLQN | 491 | P33981 | |
| NIQGVPQNIQDQAKH | 331 | Q99541 | |
| QLNQTLQKPHAEEQS | 846 | Q13395 | |
| SQLIQHQENNTEEKP | 181 | P17027 | |
| VTHQVKFGQQNPRQV | 46 | Q8WU90 | |
| QNLLNQAASQPPHIK | 1691 | Q9Y4F4 | |
| HRVLIKPEIQNNQKN | 296 | Q9HAU0 | |
| KQELIQHQKVQAPEQ | 196 | Q96SR6 | |
| HQKLKLSHFQQQPQQ | 441 | O15016 | |
| QTKSPQHLQQTIVGQ | 536 | O15016 | |
| SHLPQNQQQQQKLQI | 736 | Q6N021 | |
| LQQIEELKQQHSAAP | 726 | Q9H4Z2 | |
| NPQQLQPEAHFQVQL | 606 | Q9H347 | |
| KAQVQVPQQSHQQIL | 1836 | Q15911 | |
| VPQQSHQQILPQQQQ | 1841 | Q15911 | |
| AKNPQLRHLSPQQQQ | 4206 | O14686 | |
| QLAKVLQDQKHQNPV | 306 | Q8WXR4 | |
| PKLDSTQLQQLHNQV | 656 | Q86TC9 |